Skip to Content
You are currently on the new version of our website. Access the old version .
MDPIMDPI

Advanced

ARMAdvances in Respiratory Medicine
PDF
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Review
  • Open Access

2 September 2021

10 Pages

Endocrine Paraneoplastic Syndromes in Lung Cancer: A Respiratory Physician’s Perspective

,
,
and
1
Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India
2
Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India
3
Department of Pulmonary Medicine, All India Institute of Medical Sciences, New Delhi, India
*
Author to whom correspondence should be addressed.
Adv. Respir. Med.2021, 89(4), 403-412;https://doi.org/10.5603/ARM.a2021.0075
Version Notes
Order Reprints

Abstract

Lung malignancy is known to be one of the leading causes of cancer-related mortality. Endocrine paraneoplastic syndromes in lung cancer are common. These are due to secretion of various substances and not because of direct tumour invasion or me-tastasis. These syndromes have also been associated with lung cancer prognosis. This review describes the many endocrine paraneoplastic syndromes seen in lung cancer and narrates their incidence, biology, clinical features, diagnosis, and management.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
Potential Benefits and Hazards Associated with the Use of E-Cigarettes—A Guide for Practitioners and Current Status in Poland
Previous
Role of Ivermectin in Patients Hospitalized with COVID-19: A Systematic Review of Literature
Next